MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Paroxysmal asymmetric dystonic arm posturing – a less recognised but characteristic manifestation of ATP1A3-related disease

    B. Balint, C. Stephen, V. Udani, C. Sankhla, N. Barad, A. Lang, K. Bhatia (Boston, MA, USA)

    Objective: To highlight a less recognised but characteristic manifestation of ATP1A3-related disease. Background: ATP1A3 mutations cause a wide clinical spectrum, and are one of the…
  • 2019 International Congress

    Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?

    L. Jacinto-Scudeiro, G. Machado, A. Ayres, D. Burguêz, M. Polese-Bonatto, C. González-Salazar, M. Siebert, M. França Jr, M. Olchik, J. Saute (Porto Alegre, Brazil)

    Objective: We aimed to characterize cognitive functions of patients with pure and complicated HSP, and to determine the frequency of abnormal cognitive performances in the…
  • 2019 International Congress

    Clinical outcome in early-treated Sepiapterine Reductase Deficiency (SRD): A case report

    F. Nardecchia, S. Galosi, F. Manti, MT. Giannini, C. Carducci, M. Tolve, V. Leuzzi (Rome, Italy)

    Objective: To report the outcome of a 6.3-year-old girl with SRD diagnosed and treated since the fifth month of life. Background: Sepiapterin reductase deficiency (SRD)…
  • 2019 International Congress

    MDS Rare Movement Disorders Study Group Global Genetic Testing Survey: exploring the unmet needs

    R. Walker, H. Jinnah, M. Rodriguez Violante, C. Gonzalez, E. Gatto (New York, NY, USA)

    Objective: To better understand access to genetic testing at the international level. Background: One of the objectives of the Rare Diseases Study Group (RDSG) of…
  • 2019 International Congress

    Prevalence of Restless Leg Syndrome in the general population of Montevideo, Uruguay in 2018

    I. Amorin, H. Hackembruch, A. Lescano, M. Aguerre, O. Echevarria, S. Faliveni, J. García, E. Monllor (Montevideo, Uruguay)

    Objective: A transverse study was projected in order to determine the prevalence of Restless Leg Syndrome in the general population of Montevideo, estimate the severity…
  • 2019 International Congress

    Entity of excessive daytime sleepiness in Parkinson’s disease

    O. Iakovleva, O. Levin, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine frequency and reasons of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Neurodegeneration and dopaminergic medications are known to…
  • 2019 International Congress

    Sleep quality in Turkish patients with Parkinson’s disease

    E. Tur, M. Demir, G. Kenangil, F. Domaç (Istanbul, Turkey)

    Objective: The aim of our study is to investigate the quality of sleep and the prevalence of excessive daytime sleepness(EDS) and nighttime problems in patients…
  • 2019 International Congress

    Safinamide in the treatment of URINARY symptoms in PARKinson’s disease (SURINPARK)

    A. Gómez López, I. Pareés Moreno, S. Fanjul Arbós, JL. López Sendon, JC. Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)

    Objective: We compared the effects of safinamide on the urinary symptoms of Parkinson's disease with other therapies. Background: Urinary symptoms (US) are common, disabling and…
  • 2019 International Congress

    A Smart Device System (Wearable technology band) to Identify New Phenotypical Characteristics in Parkinson‘s disease patients

    V. Sharma, S. Sharma (Delhi, India)

    Objective: To develop methods for analyzes and monitor of  gait data via smart device system and identify new phenotypical characteristics in PD patients. Background: Parkinson's…
  • 2019 International Congress

    The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers

    T. Xie, X. Ye, J. de Courcy, K. Golden, Y. Bao, J. Zamudio, L. Chiodo, J. Morgan (Mettawa, IL, USA)

    Objective: To quantify the impact of varying severity levels on caregivers’ burden and health-related quality of life (HRQoL). Background: PSP is a progressive disease. Patients…
  • « Previous Page
  • 1
  • …
  • 192
  • 193
  • 194
  • 195
  • 196
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley